scispace - formally typeset
H

Hai-Rim Shin

Researcher at World Health Organization

Publications -  100
Citations -  27729

Hai-Rim Shin is an academic researcher from World Health Organization. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 41, co-authored 100 publications receiving 26644 citations. Previous affiliations of Hai-Rim Shin include National Cancer Research Institute & International Agency for Research on Cancer.

Papers
More filters
Journal ArticleDOI

Serologic Response to Oncogenic Human Papillomavirus Types in Male and Female University Students in Busan, South Korea

TL;DR: In the absence of genital samples, human papillomavirus (HPV) serology may be useful to assess HPV infection in young men and women and correlates with genital HPV exposure in young women, but its meaning in youngMen is unclear.
Journal ArticleDOI

Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the republic of korea

TL;DR: Of the four major risk factors for C. sinensis infection, area was the strongest and efforts to discourage raw freshwater fish intake, treat egg carriers, and protect water sources from C. Sinensis contamination should be strengthened in the Republic of Korea.
Journal ArticleDOI

Rising prostate cancer rates in South Korea.

TL;DR: This data shows that prostate cancer incidence and mortality rates in South Korea are relatively low, but rising steadily, and the number of men diagnosed with the disease is increasing.
Journal ArticleDOI

Dietary intake, eating habits, and metabolic syndrome in Korean men.

TL;DR: The results suggest that high intake of seaweed and oily foods as well as eating habits such as eating faster and frequent overeating, are associated with the risk of metabolic syndrome.
Journal ArticleDOI

Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis

TL;DR: HCC risk because of high/detectable HBV DNA and HBeAg infection was higher than HBsAg infection, whereas anti‐HCV vs anti-HCV/HCV RNA was not different, and HCC risk was significantly higher in nonendemic than in HBV or HCV endemic areas.